Brenton L. Saunders
2014
In 2014, Brenton L. Saunders earned a total compensation of $36.6M as Chairman, President & Chief Executive Officer at Allergan.
Compensation breakdown
| Non-Equity Incentive Plan | $1,541,250 |
|---|---|
| Option Awards | $8,585,568 |
| Salary | $500,000 |
| Stock Awards | $25,931,824 |
| Other | $55,187 |
| Total | $36,613,829 |
Saunders received $25.9M in stock awards, accounting for 71% of the total pay in 2014.
Saunders also received $1.5M in non-equity incentive plan, $8.6M in option awards, $500K in salary and $55.2K in other compensation.
Rankings
In 2014, Brenton L. Saunders' compensation ranked 35th out of 13,032 executives tracked by ExecPay. In other words, Saunders earned more than 99.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 35 out of 13,032 | 100th |
Division Manufacturing | 10 out of 4,966 | 100th |
Major group Chemicals And Allied Products | 4 out of 1,686 | 100th |
Industry group Drugs | 4 out of 1,365 | 100th |
Industry Pharmaceutical Preparations | 4 out of 1,043 | 100th |
Source: SEC filing on March 24, 2017.
Saunders' colleagues
We found four more compensation records of executives who worked with Brenton L. Saunders at Allergan in 2014.